主页 > 国内 >

忏悔录

China approves first-ever drug for acute mountain sickness prevention_我的网站

名侦探柯南

一 | （新加坡讯）躺在国大和南大厕所内，要求女学生帮忙扶起，54岁男子却没穿好裤子，向女学生暴露下体，还要求对方帮忙穿好裤子。男子梁文伟（译音）后来也在拉扎鲁斯岛（Lazarus Island）全裸骑脚踏车，因在公共场所裸露，被控上法庭。

二 | 根据《联合早报》报道指出，被告面对5项抵触杂项（公共秩序和滋扰）法令的罪名，他于8月28日（周三）在庭上承认其中3项，余项交由法官下判时一并考虑。

Medicine File photo: VCG
China has granted marketing approval of its first drug for the prevention of acute mountain sickness, filling the long-standing gap in the domestic market where no such medications had been available, Science and Technology Daily reported on Tuesday.
The National Medical Products Administration (NMPA) has approved the marketing of acetazolamide sustained-release capsules, the report said. As the first specialized drug in China indicated for preventing of acute mountain sickness, its approval marks the end of the country's lack of dedicated preventive treatment for altitude illness.
By inhibiting the activity of carbonic anhydrase, acetazolamide promotes the renal excretion of bicarbonate, corrects respiratory alkalosis caused by hypoxia at high altitudes, thereby regulating acid-base balance, optimizing respiratory status, elevating blood oxygen levels, and reducing the risk of onset at the source.
In contrast to health products that only provide auxiliary regulatory effects, this medication has been validated through stringent clinical trials and stands as a specialized drug approved by the NMPA with a clear indication for prevention, said the report.
Led by principal investigator is Luobu Gesang, a deputy dean of the People's Hospital of Xizang Autonomous Region, the clinical trial was designed by his team and has yielded critical evidence to inform prevention strategies for altitude sickness that are specifically adapted to Chinese and Asian populations.
"Previously, although acetazolamide had already been used internationally for the prevention of acute mountain sickness, China had long lacked an NMPA-approved acetazolamide formulation supported by rigorous clinical trials. Furthermore, the existing international formulations were short-acting tablets requiring multiple daily doses, and no drugs with the relevant indication were available on the domestic market for an extended period," said Luobu Gesang.
The sustained-release capsule approved this time not only fills this critical gap but also optimizes the dosage form, providing more reliable and convenient medication protection for the physical health and life safety of people entering high-altitude areas, he added.
Clinical trials showed that, compared with the placebo group, the incidence of acute mountain sickness in the medication group was significantly reduced, with the incidence of moderate-to-severe acute mountain sickness decreasing by 14.6 percent, according to the report.
Related research has been published in the international flagship journal of high-altitude medicine, High Altitude Medicine & Biology.
Global Times
。被告梁文伟面对5项抵触杂项（公共秩序和滋扰）法令的罪名，他周三（28日）在庭上承认其中3项，余项交由法官下判时一并考虑。

三 | 根据案情，去年5月23日，一名新加坡国立大学的女学生报案，指一名男子在国大大学城李棕体艺中心（Stephen Riady Centre）的无障碍厕所内向女学生暴露下体。

四 | 调查显示，被告在18日晚上10时来到大学的无障碍厕所；他躺在厕所内，向一名女生呼救。看到被告躺在厕所地上，女生便要求女友人即报案者帮忙。

五 | 两人此时发现被告的裤子拉下，下体完全暴露，被告则指他的手肘和膝盖受伤。两名女生帮忙扶起被告，而在前者一再催促下，被告才把裤子拉上。女友人事后报警。一周内到两大学以相同方式向女大生“露宝”庭上透露，被告也在事发5天后在新加坡南洋理工大学犯案。被告以相同方式向一名女学生求助，并向对方暴露下体。被告事后还要求对方帮忙穿裤子，但被拒绝，女学生后来报警。调查显示，当天早些时候，被告也曾向另一名女子暴露下体。根据法庭文件，去年11月14日，被告也在拉扎鲁斯岛全身赤裸骑脚踏车。